Skip to content

Changes in cortisol, oxytocin, mood and facial expression before and after aesthetic treatment

Changes in cortisol, oxytocin, mood and facial expression before and after aesthetic treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030220592
Enrollment
40
Registered
2023-01-30
Start date
2023-01-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relaxation and stress reduction effects

Interventions

Facial esthetic treatment
D004954

Sponsors

Hayashi Akito
Lead Sponsor
Miss Paris Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study subjects will be divided into three groups: Group A, Group B, and Group C. Group A will be the general public who receive facial esthetic treatment from Miss Paris Inc. for the first time; Group B will be the regular treatment applicants who receive facial esthetic treatment from Miss Paris Inc. for the first time; and Group C will be the regular treatment applicants who have undergone Miss Paris' facial esthetic treatment at least three times. Based on the above, the following selection criteria will be used. (1) Men and women who are 20 years of age or older at the time of obtaining consent. (2) Those who entered between January 10, 2023 and January 31, 2023 (however, the entry period may be extended if the number of applicants during the period indicated on the left falls far below the target number of cases). (3) Those who, after receiving a full explanation of their participation in this study, have obtained the free and voluntary written consent of the research subjects themselves based on a full understanding of the study.

Exclusion criteria

Exclusion criteria: (1) Those who have a disease that would interfere with the performance of facial esthetics (infectious skin disease, keloids, etc.) (2) Other subjects whom the principal investigator deems inappropriate as research subjects.

Design outcomes

Primary

MeasureTime frame
Measurement of cortisol and oxytocin levels by saliva test

Secondary

MeasureTime frame
Mood assessment using the Japanese version of the POMS2 short version for adults. Evaluation of health-related quality of life using the Japanese version of the SF-8 24-hour version. Survey of awareness and satisfaction using a questionnaire (VAS). Facial expression analysis using the Kokoro Sensor.

Contacts

Public ContactEmiri Gondo

Juntendo University Graduate School of Medicine

e-gondo@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026